The Effect of Acupressure and Reiki on Pain and Fatigue Levels

July 22, 2022 updated by: HEDİYE UTLİ, Mardin Artuklu University

The Effect of Acupressure and Reiki on Pain and Fatigue Levels in Cancer Patients Receiving Palliative Care

This research was conducted with the aim of determining the effect of levels of pain and fatigue of acupressure and Reiki application on cancer patients receiving palliative care. The research was a single-blind, repeated measures, randomized controlled study. Research data were collected between February and July 2022. The research sample consisted of acupressure and Reiki application groups and a control group with 52 patients in each group, a total of 156 patients. Data was collected by means of a Patient Description Form, an Analgesic Follow-up Form, the Eastern Cooperative Oncology Group Performance Status Scale, the Numeric Pain Rating Scale, and the Brief Fatigue Inventory.

Study Overview

Study Type

Interventional

Enrollment (Actual)

156

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Mardin, Turkey, 47200
        • Hediye Utli

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. having a diagnosis of third or fourth-stage cancer,
  2. being aged 18 years or older,
  3. having had pain for at least one month in connection with cancer treatment or the symptoms of the disease,
  4. using NSAII or non-opioid analgesics,
  5. having a status of 3 or more on the Numeric Pain Rating Scale (NPRS),
  6. having a score of 0-3 on the ECOG-PS scale

Exclusion Criteria:

  1. having a diagnosis of first or second-stage cancer,
  2. being aged less than 18 years,
  3. having bone or brain metastasis,
  4. using opioid analgesics,
  5. having a status of less than 3 on the NPRS,
  6. having a status of between 4 and 5 on the ECOG-PS scale

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control
No intervention.
Experimental: Acupressure
Acupressure intervention
Acupressure
Experimental: Reiki
Reiki intervention
Reiki

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Numeric Pain Rating Scale
Time Frame: on the second day of the starting week
A score of 0 indicates no pain, 1-3 slight pain, 4-6 moderate pain, and 7-10 severe pain .
on the second day of the starting week
Brief Fatigue Inventory
Time Frame: on the second day of the starting week
It is scored between 0 and 10.
on the second day of the starting week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 11, 2022

Primary Completion (Actual)

July 21, 2022

Study Completion (Actual)

July 21, 2022

Study Registration Dates

First Submitted

July 21, 2022

First Submitted That Met QC Criteria

July 22, 2022

First Posted (Actual)

July 26, 2022

Study Record Updates

Last Update Posted (Actual)

July 26, 2022

Last Update Submitted That Met QC Criteria

July 22, 2022

Last Verified

July 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • HUTLİ

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Fatigue

Clinical Trials on Acupressure intervention

Subscribe